HR + /HER2- samples exhibited dynamic equilibrium in age and APOBEC signatures, suggesting that alternative mutational processes might dominate tumor behavior later in the tumor lifetime (Supplementary Fig. 4c). This evidence concerns the gene ERBB2 and neoplasm.